Biomedical Synergies Inc is categorized under Business Consultants in Wayzata, MN and active since 2005.
Biomedical Synergies Inc was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 5619900 by the NAICS.
If you are seeking more information, feel free to contact Paul Kozloski at the company’s single location by writing to 3034 Northview Road, Wayzata, Minnesota MN 55391 or by phoning (952) 471-0361. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biomedical Synergies Inc |
| Contact Person: | Paul Kozloski |
| Address: | 3034 Northview Road, Wayzata, Minnesota 55391 |
| Phone Number: | (952) 471-0361 |
| Website Address: | biomedicalsynergies.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 5619900 |
| Share This Business: |
Biomedical Synergies Inc was started in 2005 to provide professional Business Consultants under the SIC code 8748 and NAICS code 5619900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Paul Kozloski for inquiries that concern Biomedical Synergies Inc by calling the company number (952) 471-0361, as your correspondence is most welcome. Additionally, the physical location of the single location of Biomedical Synergies Inc can be found at the coordinates 44.94121,-93.599615 as well as the street address 3034 Northview Road in Wayzata, Minnesota 55391.
For its online presence, you may visit Biomedical Synergies Inc’s website at biomedicalsynergies.com and engage with its social media outlets through on Twitter and on Facebook.